Trials / Completed
CompletedNCT01665170
Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)
A Randomized, Double Blind, Placebo-controlled Pilot Study on the Efficacy of Passiflora Incarnata L. in an Acute Stressful Situation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Pascoe Pharmazeutische Praeparate GmbH · Industry
- Sex
- All
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, double blind, placebo-controlled pilot study on the efficacy of Passiflora incarnata L. in an acute stressful situation
Detailed description
Randomized, double-blind, placebo-controlled, single-center study During Visit 1 study information and an informed consent form are handed out. After study inclusion on Visit 2, participants are assigned to one of two groups at random and receive the test products (either Pascoflair® or placebo tablets). The 3rd visit includes the completion of questionnaires regarding wellbeing and the Trier Social Stress Test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Passiflora incarnata | 3 x 1 tablet per day for 3 days |
| DRUG | Placebo | 3 x 1 ablet per day for 3 days |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-08-15
- Last updated
- 2015-12-09
- Results posted
- 2015-12-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01665170. Inclusion in this directory is not an endorsement.